Vedolizumab for acute gastrointestinal graft-versus-host disease: A systematic review and meta-analysis

Vedolizumab for acute gastrointestinal graft-versus-host disease: A systematic review and meta-analysis

ObjectiveTo determine the safety and efficacy of vedolizumab for the prophylaxis and treatment of gastrointestinal involvement of acute graft-versus-host disease (GVHD) (GI-aGVHD).MethodsLiterature search within PubMed, EMBASE, Web of Science, and Cochrane Library for observational studies and clini...

Full description

Bibliographic Details
Main Authors: Allen Cheng-Wei Li, Chen Dong, Soon-Tzeh Tay, Ashwin Ananthakrishnan, Kevin Sheng-Kai Ma
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Immunology
Subjects:
vedolizumab
graft-versus-host disease
biologics
alpha-4-beta-7 integrins
acute GVHD
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1025350/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.1025350/full

Similar Items